In summary, our study provides a molecular basis for SLC44A2 as a potential tumor suppressor in CRC by downregulating CPT2-mediated mitochondrial FAO in a MUL1-dependent manner (Graphical abstract, generated using the Microsoft PowerPoint software). The gene discussed is CPT2; the disease is colorectal carcinoma.